- Home
- BMRN vs COKE Comparison
BMRN vs COKE Comparison
Compare BMRN & COKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- COKE
- Stock Information
- Founded
- BMRN 1996
- COKE 1902
- Country
- BMRN United States
- COKE United States
- Employees
- BMRN N/A
- COKE N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- COKE Beverages (Production/Distribution)
- Sector
- BMRN Health Care
- COKE Consumer Staples
- Exchange
- BMRN Nasdaq
- COKE Nasdaq
- Market Cap
- BMRN 12.1B
- COKE 9.8B
- IPO Year
- BMRN 1999
- COKE N/A
- Fundamental
- Price
- BMRN $54.97
- COKE $111.70
- Analyst Decision
- BMRN Buy
- COKE
- Analyst Count
- BMRN 22
- COKE 0
- Target Price
- BMRN $93.43
- COKE N/A
- AVG Volume (30 Days)
- BMRN 2.2M
- COKE 713.0K
- Earning Date
- BMRN 08-04-2025
- COKE 07-30-2025
- Dividend Yield
- BMRN N/A
- COKE 0.90%
- EPS Growth
- BMRN 152.82
- COKE 32.28
- EPS
- BMRN 2.71
- COKE 6.42
- Revenue
- BMRN $2,950,227,000.00
- COKE $6,888,067,000.00
- Revenue This Year
- BMRN $12.23
- COKE N/A
- Revenue Next Year
- BMRN $9.99
- COKE N/A
- P/E Ratio
- BMRN $20.28
- COKE $17.35
- Revenue Growth
- BMRN 19.36
- COKE 3.21
- 52 Week Low
- BMRN $52.93
- COKE $105.21
- 52 Week High
- BMRN $94.85
- COKE $146.09
- Technical
- Relative Strength Index (RSI)
- BMRN 40.74
- COKE 48.62
- Support Level
- BMRN $53.76
- COKE $107.21
- Resistance Level
- BMRN $56.25
- COKE $109.61
- Average True Range (ATR)
- BMRN 1.26
- COKE 2.50
- MACD
- BMRN 0.06
- COKE 0.76
- Stochastic Oscillator
- BMRN 28.09
- COKE 82.93
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About COKE Coca-Cola Consolidated Inc.
Coca-Cola Consolidated Inc distributes, markets and manufactures nonalcoholic beverages. It offer a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages and the Company's principal sparkling beverage is Coca Cola. Still beverages include energy products and noncarbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices and sports drinks. The Company has three operating segments: Nonalcoholic Beverages, All Other and Eliminations. key revenue is generated from Nonalcoholic Beverages.